Scientific News Boston Scientific Sees Success In Pfa Device Trial
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Sees Success In Pfa Device Trial is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific’s global pulsed field ablation trial targets persistent atrial fibrillation growth
Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ... Read More
Boston Scientific sustains momentum in the PFA market: What's next?
Atrial fibrillation (AF or AFib) is one of the most common abnormal heart rhythms, affecting nearly 38 million people worldwide — a figure projected to nearly triple by 2030. Boston Scientific BSX ... Read More
Boston Scientific: Gangbusters Growth, And A Valuation To Match
Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX stock here. Read More
Boston Scientific Secures CE Mark for Farapoint Catheter, Strengthening Position in PFA
Boston Scientific is proving itself to be a pivotal force in the pulsed-field ablation space. The Marlborough, MA-based company continues to be at the forefront of PFA with its technology The firm ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus